FER1L4 and liver cancer: Therefore, in this study, anti-Ago2 antibodies were used in RNA immunoprecipitation (RIP) experiments in liver cancer cisplatin-resistant cell extracts to determine whether FER1L4 and miR-106-5p/miR-372-5p belong to the same RISC.